| 标题 |
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Benjamin A. Fisher; Xavier Mariette; Athena Papas; Thomas Grader‐Beck; Hendrika Bootsma; et al 出版日期:2024-07-31 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)